Cowealth Medical China Co.,Ltd. (SHA:603122)

Cowealth Medical China Revenue

Cowealth Medical China had revenue of 172.34M CNY in the quarter ending September 30, 2026, a decrease of -4.89%. This brings the company's total for the last twelve months to 640.00M, down -17.63% year-over-year. In the year 2025, Cowealth Medical China had annual revenue of 677.79M, down -27.83%. That makes Cowealth Medical China the 22,979th largest company in the world by revenue and 4,175th in China.

• Revenue (ttm): 640.00M
• Revenue Growth: -17.63%
• P/S Ratio: 6.54
• Revenue / Employee: 3.98M
• Employees: 161
• Market Cap: 4.19B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• In-Vitro Diagnostic Product Intensive Business 625.94M 92.4%
• Medical Product Distribution 50.54M 7.5%
• Other Value-Added Services 1.04M 0.2%

By Geography

Chart

• Mainland China 673.75M 99.4%
• Other 4.04M 0.6%

Fiscal year ended Dec 31, 2025 See the full Cowealth Medical China breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	677.79M	-261.35M	-27.83%
Dec 31, 2024	939.14M	-153.46M	-14.05%
Dec 31, 2023	1.09B	-187.06M	-14.62%
Dec 31, 2022	1.28B	88.61M	7.44%
Dec 31, 2021	1.19B	102.04M	9.37%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error